dslavcheva

Tchaikapharma High Quality Medicines Inc. Thursday announced that August sales of its leading lipid-lowering agent exceeded forecasts to reach 30,000 patients. This figure amounts to 20% of all patients indicated for such treatment and almost equals the number of patients on lipid lowering therapy 3 years ago, when Tchaikapharma started its nation-wide disease awareness campaign. Tchaikapharma’s...